-
The continuous rediscovery and the benefit–risk ratio of thioguanine, a comprehensive review
Bayoumy, A. B., Simsek, M., Seinen, M. L., Mulder, C. J. J., Ansari, A., Peters, G. J. & De Boer, N. K., 1 Feb 2020, In: Expert Opinion on Drug Metabolism and Toxicology. 16, 2, p. 111-123 13 p.Research output: Contribution to journal › Review article* › Academic › peer-review
-
The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures
Narayan, R. S., Fedrigo, C. A., Brands, E., Dik, R., Stalpers, L. J. A., Baumert, B. G., Slotman, B. J., Westerman, B. A., Peters, G. J. & Sminia, P., 21 Mar 2017, In: BMC cancer. 17, 1, p. 204 204.Research output: Contribution to journal › Article* › Academic › peer-review
-
The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2
Sarkisjan, D., Julsing, J. R., Smid, K., de Klerk, D., van Kuilenburg, A. B. P., Meinsma, R., Lee, Y. B., Kim, D. J. & Peters, G. J., 9 Sept 2016, In: PLoS ONE. 11, 9, p. e0162901Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
